Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pappa

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Abdominal Radiology (New York)|October 31, 2021
A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic cancerMaria P Fergadi, Dimitrios E Magouliotis, Christos Rountas, et al.
Mediators of Inflammation|September 24, 2011
Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatmentK Sfiridaki, C A Pappa, G Tsirakis, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteersPeter J Ruane, Andrew D Luber, Mary Beth Wire, et al.
Leukemia Research|November 3, 2015
Potential role of FLT3-ligand in the angiogenic process of multiple myelomaM Kokonozaki, G Tsirakis, M Devetzoglou, et al.
Alimentary Pharmacology & Therapeutics|April 24, 1999
Low-dose ranitidine for the relief of heartburnK A Pappa, W M Gooch, K Buaron, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 1, 2015
High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activityMaria Devetzoglou, Rodanthi Vyzoukaki, Maria Kokonozaki, et al.
Medical Oncology (Northwood, London, England)|November 27, 2013
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myelomaGeorge Tsirakis, Parascevi Roussou, Constantina A Pappa, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 25, 2014
Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myelomaC A Pappa, G Tsirakis, M Devetzoglou, et al.
Leukemia Research|November 16, 2004
Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromesMichael G Alexandrakis, Freda H Passam, Constantina A Pappa, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activityM G Alexandrakis, F H Passam, C A Pappa, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Abdominal Radiology (New York)|October 31, 2021
A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic cancerMaria P Fergadi, Dimitrios E Magouliotis, Christos Rountas, et al.
Mediators of Inflammation|September 24, 2011
Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatmentK Sfiridaki, C A Pappa, G Tsirakis, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteersPeter J Ruane, Andrew D Luber, Mary Beth Wire, et al.
Leukemia Research|November 3, 2015
Potential role of FLT3-ligand in the angiogenic process of multiple myelomaM Kokonozaki, G Tsirakis, M Devetzoglou, et al.
Alimentary Pharmacology & Therapeutics|April 24, 1999
Low-dose ranitidine for the relief of heartburnK A Pappa, W M Gooch, K Buaron, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 1, 2015
High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activityMaria Devetzoglou, Rodanthi Vyzoukaki, Maria Kokonozaki, et al.
Medical Oncology (Northwood, London, England)|November 27, 2013
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myelomaGeorge Tsirakis, Parascevi Roussou, Constantina A Pappa, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 25, 2014
Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myelomaC A Pappa, G Tsirakis, M Devetzoglou, et al.
Leukemia Research|November 16, 2004
Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromesMichael G Alexandrakis, Freda H Passam, Constantina A Pappa, et al.
International Journal of Immunopathology and Pharmacology|March 6, 2004
Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activityM G Alexandrakis, F H Passam, C A Pappa, et al.
Pageof 16